<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33223039</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-7855</ISSN><JournalIssue CitedMedium="Internet"><Volume>258</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Progress in brain research</Title><ISOAbbreviation>Prog Brain Res</ISOAbbreviation></Journal><ArticleTitle>Is the ALS a motor neuron disease or a hematopoietic stem cell disease?</ArticleTitle><Pagination><StartPage>381</StartPage><EndPage>396</EndPage><MedlinePgn>381-396</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/bs.pbr.2020.09.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0079-6123(20)30164-3</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Amyotrophic lateral sclerosis (ALS) is also known as motor neuron disease (MND) or Lou Gehrig's disease. It is a fatal neurodegenerative disease the cause of which is not clear. The effective therapy is absent. ALS is diagnosed through clinical examination and neurophysiologic tests. Clinically, the symptoms manifest when about 80% of motor neurons are dead.</AbstractText><AbstractText Label="MATERIALS AND METHODS">The hematopoietic stem cells are isolated through administration of the granulocyte colony-stimulating factor from three groups: group 1 of 62 ALS cases, group 2 of 54 ALS-free healthy donors and group 3 of 6 ALS-free ALS-family members. The expression of HLA-DR, CD38, CD117, CD13, CD33, CD56, Thy-1, CD45, &#x421;D10, CD71 was assessed in 86 samples of HSCs in ALS group, 61 samples of HSCs in healthy group and 6 samples from ALS-free ALS-family members by the multiparameter flow cytometry.</AbstractText><AbstractText Label="RESULTS">The obtained immunophenotypic profiles of HSCs membrane antigens of the ALS group significantly differ from the ALS-free group, while the immunophenotypic profiles of HSCs membrane antigens of the ALS-family members group are close to the ALS group.</AbstractText><AbstractText Label="DISCUSSION">We suppose that the ALS onset as the disease of HSCs and manifests in the genome and proteome of the HSCs. Such immunophenotypic profiling might permit identification of ALS-specific immune insufficiency and become a tool for early diagnostics of the ALS before clinical manifestation of the disease. New options of the updated therapy of ALS might be developed or corrected considering this new evidence.</AbstractText><AbstractText Label="CONCLUSION">Further research with larger samples and deeper examination is required.</AbstractText><CopyrightInformation>&#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bryukhovetskiy</LastName><ForeName>Andrey S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Central Clinical Hospital of the Russian Academy of Science, Moscow, Russia; NeuroVita, Clinic of Interventional Neurology and Rehabilitation Therapy, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grivtsova</LastName><ForeName>Lyudmila Y</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>A. Tsyb Medical Radiological Center of the FGBU National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Hari Shanker</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>International Experimental Central Nervous System Injury &amp; Repair (IECNSIR), Department of Surgical Sciences, Anesthesiology &amp; Intensive Care Medicine, Uppsala University Hospital, Uppsala University, Uppsala, Sweden. Electronic address: sharma@surgsci.uu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Prog Brain Res</MedlineTA><NlmUniqueID>0376441</NlmUniqueID><ISSNLinking>0079-6123</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006412" MajorTopicYN="N">Hematopoietic Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Hematopoietic stem cells</Keyword><Keyword MajorTopicYN="N">Immunophenotypic profile</Keyword><Keyword MajorTopicYN="N">MND</Keyword><Keyword MajorTopicYN="N">Membrane antigens</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>23</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33223039</ArticleId><ArticleId IdType="doi">10.1016/bs.pbr.2020.09.005</ArticleId><ArticleId IdType="pii">S0079-6123(20)30164-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>